Back to mobile site

AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance

July 14, 2026 6:04 AM EDT

AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $86.61 million versus the consensus estimate of $80.24 million.

GUIDANCE:

AngioDynamics sees FY2027 EPS of ($0.29)-$0.24, versus the consensus of ($0.20). AngioDynamics sees FY2027 revenue of $336-341 million, versus the consensus of $314 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK